kittybiscuits

31/1/2025 07:24

Read Full ThreadReply

You haven’t got it right for 3 years! You have consistently said it’ll be zero pence for 3 years and haven’t been right once. Moreover you tell so many lies on a daily basis, you are bound to be right at some point! Even a clock with no batteries is right twice a day.

neutralpov

30/1/2025 21:30

Read Full ThreadReply

Jeannie: "Isn't it odd how NPOV has got the EDEN shate price consistently correct for 3 years but they all hate and mock him?"

Answer: This is an insignificant obscure tadpole company, expertise mainly in puffery RNSs. Not in sales. No one is interested in it. There aren't many different humans here on this obscure discussion board, one multi-ID PoS evidently paid to tell lies about its prospects, and a few trapped bulls, several also multi-ID, desperate to engineer a spike.

ARE YOU STILL SURPRISED THAT THE OBVIOUS TRUTH GETS SO MUCH HATE HERE?
30 years without profits, let alone (haha) dividends, and a disgraceful share price chart... all plain to see, obvious to even the most meagre intellect.

ROTFL!

kittybiscuits

30/1/2025 20:03

Read Full ThreadReply

And likewise, I expect one day you will slip away and never be heard of again once the share price climbs.

The board won’t be as funny then, but your presence won’t be missed. Maybe you make your own tracks knowing you missed out.

kittybiscuits

30/1/2025 14:09

Read Full ThreadReply

No further evidence is required. Just look at any of the thousands of posts over the last 3 years. On a stock he doesn’t even own!!

alchemy

30/1/2025 12:41

Read Full ThreadReply

Very good ; and very good !

alchemy

30/1/2025 11:53

Read Full ThreadReply

Oh So when might the gun go off? Bearing in mind my limited knowledge is Ecovolex in the parallel delay universe ?

supersonico

30/1/2025 08:42

Read Full ThreadReply

supersonico - 03 Dec 2019 - 15:33:50 - 7197 of 19826 Eden Research - EDEN
Investing, you say
'I very much doubt others will co-ordinate all that you suggest'.

Who are the 'others' you mention?

If I was not under strict self imposed NDAs myself I could quite easily quote references to further substantiate my assertions regarding a shared formulation issue.

I have been the most consistent and accurate of this position for easily two years now and despite comfort updates from Eden my theory on parallel delays remains intact.

supersonico

30/1/2025 08:41

Read Full ThreadReply

supersonico - 29 Mar 2021 - 09:42:39 - 8975 of 19826 Eden Research - EDEN
In short expect Parallel Parallel delays.

kittybiscuits

29/1/2025 22:03

Read Full ThreadReply

You are a total ignorant moron.

kittybiscuits

29/1/2025 06:36

Read Full ThreadReply

Yeah, yeah, yeah. More lies from NPOV.

neutralpov

28/1/2025 23:48

Read Full ThreadReply

Thank you, supersonico. In general, it may be handy to keep an eye on what mad people and crooks do.......

I will take only partial credit for BGF's Seeing The Light.

But if one aggressive phone call from an (alleged) aggrieved BGF holder can accomplish so much, it must have been being considered already as a dump target,

BGF, the only respectable institutional investor, departing, and the Trough of Directors increasing its aggregate holding by a third to a still paltry 1.34%, aside, please summarise this extraordinarily long series of C&Ps.

Give us a Movements version which wholly ignores aggregators like Hargreaves Lansdown, Interactive Investor, Gresham House, Finn and other nominee company operators.

I know from what you shared earlier that you have access to more than RNSs and statutorily-compelled disclosure documents; how you do does not concern me. Could you please put here or PM me with a list of the ten private "investors" (gurgling chuckle!!!) with most exposure to this zerobound coprophiliac's paradise.

Thank you. It will be helpful as we move to the endgame for a few window-lickers.... ;-)

supersonico

28/1/2025 18:38

Read Full ThreadReply

NUMBER OF AIM SECURITIES IN ISSUE
As of 28 January 2025, the number of shares in issue was 533,352,523.

SIGNIFICANT SHAREHOLDERS
As of 21 December 2024, significant shareholdings in the share capital of Eden Research plc were:

Name
Number of shares
% of the issued ordinary share capital

Hargreaves Lansdown
56,608,629
10.61%

Gresham House Asset Management Limited
52,882,786
9.92%

Interactive Investor
44,756,732
8.39%

Octopus Investments
41,551,047
7.79%

Sipcam Oxon S.p.A.
39,285,138
7.37%

Canaccord Genuity Wealth Management
30,201,307
5.66%

Atul Unadkat
23,486,291
4.40%

Unicorn Asset Management
23,076,923
4.33%

J M Finn
22,381,562
4.20%

Rathbones
21,567,400
4.04%

Amati Global Investors
16,744,070
3.14%

As of 28 January 2025, the directors' shareholdings in the share capital of Eden Research plc were:

Name

Number of shares

% of the issued ordinary share capital

A Abrey
2,314,732
0.43%

S Smith
1,913,117
0.36%

L van der Broek
1,621,808
0.30%

R Cridland
745,552
0.14%

D McAllan
323,017
0.11%
...........................


NUMBER OF AIM SECURITIES IN ISSUE
As of 21 June 2024, the number of shares in issue was 533,352,523.

As of 21 June 2024 significant shareholdings in the share capital of Eden Research plc were:

Name
Number of shares
% of the issued ordinary share capital

Hargreaves Lansdown
56,037,526
10.51%

Gresham House Asset Management Limited
52,882,786
9.92%

Interactive Investor
41,915,712
7.86%

Octopus Investments
41,551,047
7.79%

Sipcam Oxon S.p.A.
39,285,138
7.37%

Canaccord Genuity Wealth Management
30,276,307
5.68%

Unicorn Asset Management
23,076,923
4.33%

Rathbones
23,040,287
4.32%

Atul Unadkat
22,964,424
4.31%

JM Finn Nominees Limited
19,955,562
3.74%

Amati Global Investors
16,744,070
3.14%

Name
Number of shares
% of the issued ordinary share capital

A Abrey
1,774,192
0.33%

L van der Broek
1,621,808
0.30%

S Smith
1,192,577
0.22%

R Cridland
745,552
0.14%
....................................

NUMBER OF AIM SECURITIES IN ISSUE
As of 3 January 2024, the number of shares in issue was 533,352,523.

SIGNIFICANT SHAREHOLDERS
As of 3 January 2024 significant shareholdings in the share capital of Eden Research plc were:

Name

Number of shares

% of the issued ordinary share capital

Hargreaves Lansdown
53,364,313
10.01%

Gresham House Asset Management Limited
52,882,786
9.92%

Octopus Investments
41,551,047
7.79%

Sipcam Oxon S.p.A.
39,285,138
7.37%

Interactive Investor
33,363,457
6.26%

Canaccord Genuity Wealth Management
30,276,307
5.68%

Unicorn Asset Management
23,076,923
4.33%

Rathbones
23,040,287
4.32%

Atul Unadkat
22,099,924
4.14%

JM Finn Nominees Limited
20,147,562
3.78%

Amati Global Investors
16,744,070
3.14%

BGF Investment Management Limited
16,000,576
3.00%

............................

As of 20 July 2023, the number of shares in issue was 381,108,607.

SIGNIFICANT SHAREHOLDERS
As of 20 July 2023 significant shareholdings in the share capital of Eden Research plc were:

Name
Number of shares
% of the issued ordinary share capital

Hargreaves Lansdown
45,307,219
11.89%

Sipcam Oxon S.p.A.
37,614,830
9.87%

Interactive Investor
31,957,945
8.39%

Gresham House Asset Management Limited
27,845,445
7.31%

Canaccord Genuity Group Inc
22,584,000
5.93%

BGF Investment Management Limited
20,233,000
5.31%

JM Finn Nominees Limited
19,635,562
5.15%

Atul Unadkat
18,811,765
4.94%

Rathbone Nominees Limited
13,661,661
3.58%

HSBC Global Custody Nominee (UK) Limited
13,066,384
3.43%

HSDL Stockbrokers
12,436,733
3.26%


Name
Number of shares
% of the issued ordinary share capital

A Abrey
1,620,346
0.43%

L van der Broek
929,500
0.24%

S Smith
911,039
0.24%

R Cridland
130,167
0.03%
...................

NUMBER OF AIM SECURITIES IN ISSUE
As of 21 March 2023, the number of shares in issue was 380,858,607.

SIGNIFICANT SHAREHOLDERS
As of 21 March 2023 significant shareholdings in the share capital of Eden Research plc were:


Name

Number of shares

% of the issued ordinary share capital

BGF Investment Management Limited
51,733,000
13.58%

Sipcam Oxon S.p.A.
37,614,830
9.88%

Hargreaves Lansdown
31,737,596
8.33%

Gresham House Asset Management Limited
27,845,445
7.31%


Interactive Investor
25,172,555
6.61%

Canaccord Genuity Group Inc
22,584,000
5.93%

JM Finn Nominees Limited
19,839,762
5.21%

Atul Unadkat
18,117,567
4.76%

Rathbone Nominees Limited
15,621,872
4.10%

HSBC Global Custody Nominee (UK) Limited
13,066,384
3.43%



Name
Number of shares
% of the issued ordinary share capital

A Abrey
1,620,346
0.43%

L van der Broek
929,500
0.24%

S Smith
911,039
0.24%

R Cridland
130,167
0.03%


SHARES NOT IN PUBLIC HANDS
In the terms of AIM Rules published July 2016 and insofar as it is aware, at 21 March 2023, 31.71% of the Company's AIM securities was not in public hands.

.................................................................................

Atul keeps buying.

As of 30 September 2022, the number of shares in issue was 380,858,607.
As of 30 September 2022, significant shareholdings in the share capital of Eden Research plc were:

Number of shares % of the issued ordinary share capital

BGF Investment Management Limited
53,733,000
14.11%

Sipcam Oxon S.p.A.
37,614,830
9.88%

Hargreaves Lansdown
29,839,285
7.83%

Gresham House Asset Management Limited
27,845,445
7.31%


Canaccord Genuity Group Inc
22,584,000
5.93%

Interactive Investor
20,027,730
5.26%

JM Finn Nominees Limited
19,277,362
5.06%

Atul Unadkat
17,545,098
4.61%

Rathbone Nominees Limited
15,708,999
4.12%

HSBC Global Custody Nominee (UK) Limited
13,270,588
3.48%


......................................................................................................................

NUMBER OF AIM SECURITIES IN ISSUE
As of 09 March 2022, the number of shares in issue was 380,340,229.

SIGNIFICANT SHAREHOLDERS
As of 09 March 2022, significant shareholdings in the share capital of Eden Research plc were:

Name
Number of shares
% of the issued ordinary share capital

BGF Investment Management Limited
54,933,000
14.44%

Sipcam Oxon S.p.A.
37,614,830
9.89%

Gresham House Asset Management Limited
27,845,445
7.32%

Hargreaves Lansdown
25,331,396
6.66%


Canaccord Genuity Group Inc
22,584,000
5.94%

JM Finn Nominees Limited
20,386,275
5.36%

Interactive Investor
19,790,573
5.20%

Atul Unadkat
17,350,145
4.38%

Rathbone Nominees Limited
16,095,276
4.24%

Amati AIM VCT plc
14,282,652
3.76%

HSBC Global Custody Nominee (UK) Limited
13,270,588
3.49%



.....................................
NUMBER OF AIM SECURITIES IN ISSUE
As of 18 August 2021, the number of shares in issue was 380,340,229.

SIGNIFICANT SHAREHOLDERS
As of 18 August 2021, significant shareholdings in the share capital of Eden Research plc were:


Name
Number of shares
% of the issued ordinary share capital

BGF Investment Management Limited
54,933,000
14.44%

Sipcam Oxon S.p.A.
37,614,830
9.89%

Gresham House Asset Management Limited
27,845,445
7.32%

Hargreaves Lansdown
25,331,396
6.66%


Canaccord Genuity Group Inc
22,584,000
5.94%

JM Finn Nominees Limited
20,386,275
5.36%

Interactive Investor
19,790,573
5.20%

Rathbone Nominees Limited
16,122,338
4.24%

Amati AIM VCT plc
14,282,652
3.76%

HSBC Global Custody Nominee (UK) Limited
13,270,588
3.49%

...................


Home
SECURITIES INFORMATION


NUMBER OF AIM SECURITIES IN ISSUE
As of 21 February 2021, the number of shares in issue was 380,340,229.

SIGNIFICANT SHAREHOLDERS
As of 21 February 2021, significant shareholdings in the share capital of Eden Research plc were:


Name
Number of shares
% of the issued ordinary share capital

BGF Investment Management Limited
58,333,000
15.34%

Sipcam Oxon S.p.A.
37,614,830
9.89%

Gresham House Asset Management Limited
27,845,445
7.32%

Hargreaves Lansdown
25,452,709
6.69%


Canaccord Genuity Group Inc
22,584,000
5.94%

JM Finn Nominees Limited
20,421,575
5.37%

Amati AIM VCT plc
16,937,750
4.45%

Rathbone Nominees Limited
16,156,166
4.25%

Interactive Investor
15,405,978
4.05%

HSBC Global Custody Nominee (UK) Limited
14,015,588
3.69%


NUMBER OF AIM SECURITIES IN ISSUE
As of 21 August 2020, the number of shares in issue was 380,340,229.

SIGNIFICANT SHAREHOLDERS
As of 21 August 2020, significant shareholdings in the share capital of Eden Research plc were:


BGF Investment Management Limited
58,333,000
15.34%

Sipcam Oxon S.p.A.
37,614,830
9.89%

Hargreaves Lansdown
30,276,493
7.96%

Gresham House Asset Management Limited
27,845,445
7.32%

Canaccord Genuity Group Inc
22,684,000
5.94%

JM Finn Nominees Limited
21,774,435
5.72%

Amati AIM VCT plc
16,937,750
4.45%

Rathbone Nominees Limited
16,246,373
4.27%

HSBC Global Custody Nominee (UK) Limited
14,007,734
3.68%

Interactive Investor
12,992,073
3.42%


supersonico - 03 Dec 2022 - 07:03:11 - 13502 of 14935 Eden Research - EDEN
Atul keeps buying.

As of 30 September 2022, the number of shares in issue was 380,858,607.
As of 30 September 2022, significant shareholdings in the share capital of Eden Research plc were:

Number of shares % of the issued ordinary share capital

BGF Investment Management Limited
53,733,000
14.11%

Sipcam Oxon S.p.A.
37,614,830
9.88%

Hargreaves Lansdown
29,839,285
7.83%

Gresham House Asset Management Limited
27,845,445
7.31%


Canaccord Genuity Group Inc
22,584,000
5.93%

Interactive Investor
20,027,730
5.26%

JM Finn Nominees Limited
19,277,362
5.06%

Atul Unadkat
17,545,098
4.61%

Rathbone Nominees Limited
15,708,999
4.12%

HSBC Global Custody Nominee (UK) Limited
13,270,588
3.48%


......................................................................................................................

NUMBER OF AIM SECURITIES IN ISSUE
As of 09 March 2022, the number of shares in issue was 380,340,229.

SIGNIFICANT SHAREHOLDERS
As of 09 March 2022, significant shareholdings in the share capital of Eden Research plc were:

Name
Number of shares
% of the issued ordinary share capital

BGF Investment Management Limited
54,933,000
14.44%

Sipcam Oxon S.p.A.
37,614,830
9.89%

Gresham House Asset Management Limited
27,845,445
7.32%

Hargreaves Lansdown
25,331,396
6.66%


Canaccord Genuity Group Inc
22,584,000
5.94%

JM Finn Nominees Limited
20,386,275
5.36%

Interactive Investor
19,790,573
5.20%

Atul Unadkat
17,350,145
4.38%

Rathbone Nominees Limited
16,095,276
4.24%

Amati AIM VCT plc
14,282,652
3.76%

HSBC Global Custody Nominee (UK) Limited
13,270,588
3.49%



.....................................
NUMBER OF AIM SECURITIES IN ISSUE
As of 18 August 2021, the number of shares in issue was 380,340,229.

SIGNIFICANT SHAREHOLDERS
As of 18 August 2021, significant shareholdings in the share capital of Eden Research plc were:


Name
Number of shares
% of the issued ordinary share capital

BGF Investment Management Limited
54,933,000
14.44%

Sipcam Oxon S.p.A.
37,614,830
9.89%

Gresham House Asset Management Limited
27,845,445
7.32%

Hargreaves Lansdown
25,331,396
6.66%


Canaccord Genuity Group Inc
22,584,000
5.94%

JM Finn Nominees Limited
20,386,275
5.36%

Interactive Investor
19,790,573
5.20%

Rathbone Nominees Limited
16,122,338
4.24%

Amati AIM VCT plc
14,282,652
3.76%

HSBC Global Custody Nominee (UK) Limited
13,270,588
3.49%

...................


Home
SECURITIES INFORMATION


NUMBER OF AIM SECURITIES IN ISSUE
As of 21 February 2021, the number of shares in issue was 380,340,229.

SIGNIFICANT SHAREHOLDERS
As of 21 February 2021, significant shareholdings in the share capital of Eden Research plc were:


Name
Number of shares
% of the issued ordinary share capital

BGF Investment Management Limited
58,333,000
15.34%

Sipcam Oxon S.p.A.
37,614,830
9.89%

Gresham House Asset Management Limited
27,845,445
7.32%

Hargreaves Lansdown
25,452,709
6.69%


Canaccord Genuity Group Inc
22,584,000
5.94%

JM Finn Nominees Limited
20,421,575
5.37%

Amati AIM VCT plc
16,937,750
4.45%

Rathbone Nominees Limited
16,156,166
4.25%

Interactive Investor
15,405,978
4.05%

HSBC Global Custody Nominee (UK) Limited
14,015,588
3.69%


NUMBER OF AIM SECURITIES IN ISSUE
As of 21 August 2020, the number of shares in issue was 380,340,229.

SIGNIFICANT SHAREHOLDERS
As of 21 August 2020, significant shareholdings in the share capital of Eden Research plc were:


BGF Investment Management Limited
58,333,000
15.34%

Sipcam Oxon S.p.A.
37,614,830
9.89%

Hargreaves Lansdown
30,276,493
7.96%

Gresham House Asset Management Limited
27,845,445
7.32%

Canaccord Genuity Group Inc
22,684,000
5.94%

JM Finn Nominees Limited
21,774,435
5.72%

Amati AIM VCT plc
16,937,750
4.45%

Rathbone Nominees Limited
16,246,373
4.27%

HSBC Global Custody Nominee (UK) Limited
14,007,734
3.68%

Interactive Investor
12,992,073
3.42%


supersonico - 05 Oct 2022 - 08:52:18 - 13219 of 14935 Eden Research - EDEN
Selling yes..but it's a dribble which has been bought by Atul etal.

As of 30 September 2022, the number of shares in issue was 380,858,607.
As of 30 September 2022, significant shareholdings in the share capital of Eden Research plc were:

Number of shares % of the issued ordinary share capital

BGF Investment Management Limited
53,733,000
14.11%

Sipcam Oxon S.p.A.
37,614,830
9.88%

Hargreaves Lansdown
29,839,285
7.83%

Gresham House Asset Management Limited
27,845,445
7.31%


Canaccord Genuity Group Inc
22,584,000
5.93%

Interactive Investor
20,027,730
5.26%

JM Finn Nominees Limited
19,277,362
5.06%

Atul Unadkat
17,545,098
4.61%

Rathbone Nominees Limited
15,708,999
4.12%

HSBC Global Custody Nominee (UK) Limited
13,270,588
3.48%


......................................................................................................................

NUMBER OF AIM SECURITIES IN ISSUE
As of 09 March 2022, the number of shares in issue was 380,340,229.

SIGNIFICANT SHAREHOLDERS
As of 09 March 2022, significant shareholdings in the share capital of Eden Research plc were:

Name
Number of shares
% of the issued ordinary share capital

BGF Investment Management Limited
54,933,000
14.44%

Sipcam Oxon S.p.A.
37,614,830
9.89%

Gresham House Asset Management Limited
27,845,445
7.32%

Hargreaves Lansdown
25,331,396
6.66%


Canaccord Genuity Group Inc
22,584,000
5.94%

JM Finn Nominees Limited
20,386,275
5.36%

Interactive Investor
19,790,573
5.20%

Atul Unadkat
17,350,145
4.38%

Rathbone Nominees Limited
16,095,276
4.24%

Amati AIM VCT plc
14,282,652
3.76%

HSBC Global Custody Nominee (UK) Limited
13,270,588
3.49%



.....................................
NUMBER OF AIM SECURITIES IN ISSUE
As of 18 August 2021, the number of shares in issue was 380,340,229.

SIGNIFICANT SHAREHOLDERS
As of 18 August 2021, significant shareholdings in the share capital of Eden Research plc were:


Name
Number of shares
% of the issued ordinary share capital

BGF Investment Management Limited
54,933,000
14.44%

Sipcam Oxon S.p.A.
37,614,830
9.89%

Gresham House Asset Management Limited
27,845,445
7.32%

Hargreaves Lansdown
25,331,396
6.66%


Canaccord Genuity Group Inc
22,584,000
5.94%

JM Finn Nominees Limited
20,386,275
5.36%

Interactive Investor
19,790,573
5.20%

Rathbone Nominees Limited
16,122,338
4.24%

Amati AIM VCT plc
14,282,652
3.76%

HSBC Global Custody Nominee (UK) Limited
13,270,588
3.49%

...................


Home
SECURITIES INFORMATION


NUMBER OF AIM SECURITIES IN ISSUE
As of 21 February 2021, the number of shares in issue was 380,340,229.

SIGNIFICANT SHAREHOLDERS
As of 21 February 2021, significant shareholdings in the share capital of Eden Research plc were:


Name
Number of shares
% of the issued ordinary share capital

BGF Investment Management Limited
58,333,000
15.34%

Sipcam Oxon S.p.A.
37,614,830
9.89%

Gresham House Asset Management Limited
27,845,445
7.32%

Hargreaves Lansdown
25,452,709
6.69%


Canaccord Genuity Group Inc
22,584,000
5.94%

JM Finn Nominees Limited
20,421,575
5.37%

Amati AIM VCT plc
16,937,750
4.45%

Rathbone Nominees Limited
16,156,166
4.25%

Interactive Investor
15,405,978
4.05%

HSBC Global Custody Nominee (UK) Limited
14,015,588
3.69%


NUMBER OF AIM SECURITIES IN ISSUE
As of 21 August 2020, the number of shares in issue was 380,340,229.

SIGNIFICANT SHAREHOLDERS
As of 21 August 2020, significant shareholdings in the share capital of Eden Research plc were:


BGF Investment Management Limited
58,333,000
15.34%

Sipcam Oxon S.p.A.
37,614,830
9.89%

Hargreaves Lansdown
30,276,493
7.96%

Gresham House Asset Management Limited
27,845,445
7.32%

Canaccord Genuity Group Inc
22,684,000
5.94%

JM Finn Nominees Limited
21,774,435
5.72%

Amati AIM VCT plc
16,937,750
4.45%

Rathbone Nominees Limited
16,246,373
4.27%

HSBC Global Custody Nominee (UK) Limited
14,007,734
3.68%

Interactive Investor
12,992,073
3.42%


1

supersonico

28/1/2025 18:33

Read Full ThreadReply

NUMBER OF AIM SECURITIES IN ISSUE
As of 28 January 2025, the number of shares in issue was 533,352,523.

SIGNIFICANT SHAREHOLDERS
As of 21 December 2024, significant shareholdings in the share capital of Eden Research plc were:

Name
Number of shares
% of the issued ordinary share capital

Hargreaves Lansdown
56,608,629
10.61%

Gresham House Asset Management Limited
52,882,786
9.92%

Interactive Investor
44,756,732
8.39%

Octopus Investments
41,551,047
7.79%

Sipcam Oxon S.p.A.
39,285,138
7.37%

Canaccord Genuity Wealth Management
30,201,307
5.66%

Atul Unadkat
23,486,291
4.40%

Unicorn Asset Management
23,076,923
4.33%

J M Finn
22,381,562
4.20%

Rathbones
21,567,400
4.04%

Amati Global Investors
16,744,070
3.14%

As of 28 January 2025, the directors' shareholdings in the share capital of Eden Research plc were:

Name

Number of shares

% of the issued ordinary share capital

A Abrey
2,314,732
0.43%

S Smith
1,913,117
0.36%

L van der Broek
1,621,808
0.30%

R Cridland
745,552
0.14%

D McAllan
323,017
0.11%

investingisatrickygame

28/1/2025 14:22

Read Full ThreadReply

hybrasil.

I think the article you are referring to is this one from June 2023

hybrasil

28/1/2025 13:50

Read Full ThreadReply

My attention was drawn to the share by a Joanne Harte article some years ago.

I think every share has its time and I’m obviously hoping the time for Eden is now!

alchemy

28/1/2025 13:35

Read Full ThreadReply

Thank you for health warning . The context is slightly different font you think?

erinvale1

28/1/2025 13:30

Read Full ThreadReply

Don’t be fooled. Directors have purchased in the past. No effect: the share price continues to decline.